Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300063 · ClinicalTrials.gov registry record · NA
Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients
A NA study of Stroke, Acute, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03300063: Completed NA study of Stroke, Acute, sponsored by Mayo Clinic.
NCT03300063 is a NA study of Stroke, Acute that has completed, run by Mayo Clinic. The registered enrollment target is 6 participants, below the 630-participant average among 25 other Stroke, Acute trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03300063, a NA study of Stroke, Acute, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
We want to determine if treating acute ischemic stroke patients who have evidence of hypoxemia due to sleep apnea with low flow O2 during sleep might help improve clinical and functional outcomes.
Conditions Studied
Interventions
- OTHER Low flow nocturnal oxygen
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-04-03 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
What the finished NCT03300063 record still lists
NCT03300063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 630-participant average among 25 other Stroke, Acute trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention - of which Low flow nocturnal oxygen is the first listed.
NCT03300063 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03300063 about?
NCT03300063 is a clinical study titled "Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients". We want to determine if treating acute ischemic stroke patients who have evidence of hypoxemia due to sleep apnea with low flow O2 during sleep might help improve clinical and functional outcomes.
What is the current status of trial NCT03300063?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-04-03. Estimated completion is 2020-12-01.
What conditions does trial NCT03300063 study?
This clinical trial studies the following conditions: Stroke, Acute.
What interventions are being tested in trial NCT03300063?
The interventions under investigation include: Low flow nocturnal oxygen (OTHER).
Who is sponsoring clinical trial NCT03300063?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03300063 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03300063's enrollment target sits among peer trials
6 26th of 25 the lowest of 25 other Stroke, Acute trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
ECMO ABI Detection With Hyperfine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI